Court won't limit Canadian Zyprexa claims

Ontario’s highest court denied Eli Lilly's bid to limit potential damages in a lawsuit filed by Canadian patients, who claimed they developed diabetes after using the Zyprexa antipsycyotic. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.